-

Thermo Fisher Scientific Launches First More Sustainable Large-Capacity and Superspeed Centrifuges with Next-Generation Natural Refrigerant Cooling System

New Cryofuge, BIOS and LYNX centrifuges offer a significantly lower Global Warming Potential and up to 15% energy savings

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, introduced today new lines of floor-model centrifuges to provide more sustainable solutions without compromising performance and sample security. The Thermo Scientific™ Cryofuge™, Thermo Scientific™ BIOS and Thermo Scientific™ LYNX centrifuges are the first floor-model centrifuges that feature natural refrigerant cooling systems compliant with European Union (E.U.) and U.S. Environmental Protection Agency (EPA) F-gas regulations. Regulatory bodies in the E.U. and U.S. are implementing regulations to discontinue fluorinated gases as refrigerants, and centrifuge manufacturers must comply to the new prohibition timelines.

The Cryofuge, BIOS and LYNX centrifuges feature new Thermo Scientific™ GreenCool Technology, a next-generation natural refrigerant cooling system with a Global Warming Potential of 1, which is 1,397 times less impactful to the environment compared to previous technologies. They are also manufactured at Thermo Fisher’s site in Osterode am Harz, Germany, a certified zero-waste facility powered by 100% renewable energy.

In addition to the improvements in sustainability, the new lines of centrifuges weigh less and generate less noise, enhancing the laboratory environment. The features and technologies remain market-leading for floor-model centrifuges. Focused on performance, protection of user and samples, intuitive operation, and excellent reliability, they deliver precise and efficient results in areas like blood banking, bioprocessing and a broad range of research applications.

“Sustainability is a top priority as we support our customers on their own journeys to embracing greener sciences,” said Thomas Doerdelmann, vice president and general manager of growth, protection and separation at Thermo Fisher Scientific. “As the leader in superspeed and large-capacity centrifuges, we are proud to offer the first centrifuges with sustainability at the heart of design, manufacturing and operation that build upon the same market-leading quality and reliability our customers have come to trust.”

Supporting blood banking and processing
The Thermo Scientific Cryofuge 8 and 16 Blood Banking Centrifuges offer strong sample security and performance to blood processing centers in a more sustainable design. Through user-friendly features like enhanced ergonomics and easy setup of traceable runs, they help ensure compliance with global standards for efficient blood processing. In addition to the innovative cooling system, they provide a 14% reduction in energy consumption compared to previous models.

Enabling high-throughput bioprocessing
Thermo Scientific BIOS A and 16 Centrifuges deliver power and enhanced sustainability to bioprocessing facilities and labs performing high-throughput applications. They help simplify working with large sample volumes and offer up to 15% lower energy consumption than the previous models.

Powering complex and evolving research
Thermo Scientific LYNX 4000 and 6000 Superspeed Centrifuges are designed for reliability, consistent results and maximum uptime in various research and bioprocessing laboratories. Through GreenCool technology, they maintain stable deep cooling temperatures, helping ensure the integrity of temperature-sensitive samples. They can also achieve greater speeds at 4°C to enhance performance for more efficient separations. Well-suited for shared laboratory settings, the LYNX centrifuges can support multiple users and high-throughput sample processing, offering up to 13% less energy consumption.

These new centrifuges replace the line of Sorvall centrifuges previously offered by Thermo Fisher Scientific. For more information, visit www.thermofisher.com/greenercentrifuges.

* Intended use of the products mentioned in this release varies. For specific use statements, please refer to the product label.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Contacts

THERMO FISHER SCIENTIFIC

NYSE:TMO
Details
Headquarters: Waltham, Massachusetts
CEO: Marc N. Casper
Employees: 100,000
Organization: PUB
Revenues: $40 Billion (2021)

Release Versions

Contacts

More News From THERMO FISHER SCIENTIFIC

Thermo Fisher Scientific Launches the Krios 5 Cryo-Transmission Electron Microscope (TEM), Boosting Productivity and Performance With Enhanced Automation

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Krios™ 5 Cryo-TEM. This next-generation, atomic-resolution platform leverages enhanced optics and AI-enabled automation to study molecular structures and interactions at a throughput and fidelity that was previously unattainable. A Leap Forward in Imaging and Insight In the rapidly evolving field of structural biology, single particle analysis (SPA) and cryo-elec...

Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, April 23, 2025

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the first quarter 2025 before the market opens on Wednesday, April 23, 2025, and will hold a conference call on the same day at 8:30 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations. To listen, call (833) 470-1428 within the U.S. or (404) 975-4839 outside the U.S. The...

Thermo Fisher Scientific and Chan Zuckerberg Institute for Advanced Biological Imaging Collaborate to Further Understanding of Human Cells

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, has announced a Technology Alliance Agreement with the Chan Zuckerberg Institute for Advanced Biological Imaging (CZ Imaging Institute). This agreement aims to develop new technologies to enable researchers to better visualize human cells, significantly advancing scientific research and discovery. Cryo-electron microscopy (cryo-EM) is an essential tool in disease research and creating lifesaving...
Back to Newsroom